FI922667A0 - Diagnostiskt foerfarande. - Google Patents

Diagnostiskt foerfarande.

Info

Publication number
FI922667A0
FI922667A0 FI922667A FI922667A FI922667A0 FI 922667 A0 FI922667 A0 FI 922667A0 FI 922667 A FI922667 A FI 922667A FI 922667 A FI922667 A FI 922667A FI 922667 A0 FI922667 A0 FI 922667A0
Authority
FI
Finland
Prior art keywords
prosomes
extracellular
blood
suffering
diseases
Prior art date
Application number
FI922667A
Other languages
English (en)
Finnish (fi)
Inventor
Klaus Scherrer
Jean Paul Bureau
Faycal Bey
Original Assignee
Pro Soma Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pro Soma Sarl filed Critical Pro Soma Sarl
Publication of FI922667A0 publication Critical patent/FI922667A0/fi

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • G01N33/57419Specifically defined cancers of colon
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2337/00N-linked chromogens for determinations of peptidases and proteinases
    • C12Q2337/20Coumarin derivatives
    • C12Q2337/227-Amino-4-methylcoumarin, i.e. AMC, MCA
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08RNA viruses
    • G01N2333/15Retroviridae, e.g. bovine leukaemia virus, feline leukaemia virus, feline leukaemia virus, human T-cell leukaemia-lymphoma virus
    • G01N2333/155Lentiviridae, e.g. visna-maedi virus, equine infectious virus, FIV, SIV
    • G01N2333/16HIV-1, HIV-2

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Wood Science & Technology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • AIDS & HIV (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Electrotherapy Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Lubrication Of Internal Combustion Engines (AREA)
FI922667A 1990-10-12 1992-06-09 Diagnostiskt foerfarande. FI922667A0 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90402863 1990-10-12
PCT/EP1991/001946 WO1992007270A1 (en) 1990-10-12 1991-10-11 Diagnostic method

Publications (1)

Publication Number Publication Date
FI922667A0 true FI922667A0 (fi) 1992-06-09

Family

ID=8205762

Family Applications (1)

Application Number Title Priority Date Filing Date
FI922667A FI922667A0 (fi) 1990-10-12 1992-06-09 Diagnostiskt foerfarande.

Country Status (8)

Country Link
EP (1) EP0506914B1 (de)
JP (1) JPH05502799A (de)
AT (1) ATE146597T1 (de)
AU (1) AU652192B2 (de)
CA (1) CA2069417A1 (de)
DE (1) DE69123724T2 (de)
FI (1) FI922667A0 (de)
WO (1) WO1992007270A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL440782A1 (pl) * 2022-03-29 2023-10-02 Urteste Spółka Akcyjna Związek - marker diagnostyczny raka jelita, sposób wykrywania aktywności enzymatycznej, sposób diagnozowania raka jelita, zestaw zawierający taki związek oraz zastosowania takiego związku i sposób leczenia raka jelita

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586814A1 (fr) * 1985-08-30 1987-03-06 Centre Nat Rech Scient Anticorps monoclonaux anti-proteines p 27 k et p 31 k de prosomes et leur application a titre de reactifs de diagnostic et/ou d'identification de cellules
JPH01309686A (ja) * 1988-06-08 1989-12-14 Otsuka Pharmaceut Co Ltd 多機能プロテアーゼ

Also Published As

Publication number Publication date
DE69123724D1 (de) 1997-01-30
AU652192B2 (en) 1994-08-18
CA2069417A1 (en) 1992-04-13
AU8740691A (en) 1992-05-20
WO1992007270A1 (en) 1992-04-30
JPH05502799A (ja) 1993-05-20
ATE146597T1 (de) 1997-01-15
EP0506914A1 (de) 1992-10-07
DE69123724T2 (de) 1997-04-10
EP0506914B1 (de) 1996-12-18

Similar Documents

Publication Publication Date Title
DE69228436D1 (de) Monoklonaler Antikörper, der den C-Terminus von hBNP erkennt
ES2094733T3 (es) Deteccion de enfermedades o disfunciones neurologicas.
DK0528767T3 (da) antistofderivater
CA2093928A1 (en) Monoclonal antibodies for detection and treatment of cancer
EP0674661A4 (de) Test und behandlung von demyelinierenden krankheiten wie multiple sklerosis.
ES2033823T3 (es) Ensayo en cuanto a cancer de mama humano.
DE3585061D1 (de) Verwendung eines spezifischen tumorassoziierten antigens, sialosyllactotetraose, in diagnose- oder therapieverfahren bezueglich krebskrankheiten.
FI922666A0 (fi) Diagnostiskt foerfarande.
FI922667A0 (fi) Diagnostiskt foerfarande.
Morgan et al. Antigenic characterization of adult Wuchereria bancrofti filarial nematodes
KR870700023A (ko) 녹농균의 E8Ag항원 및 그것에 대한 모노클로날 항체및 하이브리도마
DE3688638D1 (de) Monoklonale antikoerper fuer humane lungenkarzinome des "nicht-kleine-zellen"-typs.
ATE93629T1 (de) Verfahren zur diagnose in vitro von menschlichen cytomegalovirusinfektionen und anwendung von monoklonalen antikoerpern gegen cytomegaloviren, die mit einer cytomegalovirusinduzierten proteinkinase reagieren.
ATE147629T1 (de) Diagnose und behandlung von neuro-cognitiven störungen assoziiert mit systemisch- immunologischer fehlfunktion
Murray et al. Blocking factors against leucocyte-dependent melanoma antibody in the sera of melanoma patients
ATE86261T1 (de) Tumorassoziiertes antigen.
SU1698764A1 (ru) Способ определени лиц, предрасположенных к респираторным заболевани м
CA2151945A1 (en) Assay and treatment for demyelinating diseases such as multiple sclerosis
KR970073606A (ko) 항 인체 인터루킨-6 항체 및 이를 이용한 인체 인터루킨-6의 검정
Harinath RIA and ELISA as diagnostic tools in the study of filariasis
Poulain Minutes of the Annual Meeting of the Belgian Society for Human and Animal Mycology, Held on March 4, 1989 at The Institute of Tropical Medicine–Antwerp: Fungal Serology
RU93020014A (ru) Способ диагностики гипофункции щитовидной железы